Barinthus Biotherapeutics plc.
BRNSDelisted Sep 9, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001828185
Barinthus Biotherapeutics plc. was delisted on Sep 9, 2026; its insiders filed their last Form 4 on Sep 11, 2026; 15 institutions reported holding it in 13F filings for Q2 2026, worth $7.84M in total; no superinvestor held it.
Holders of 5% or more of BRNS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Barinthus Biotherapeutics plc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Cawood Frank Wayne | 13G/A | 8.40%3.38M shares | – | Feb 11, 20251 filing | Feb 11, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Barinthus Biotherapeutics plc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 11, 202611:47 AM ET | Oxford Science Enterprises plc | 13G/A | 0.00%0 shares | –Below 5% | Sep 9, 2026 | SEC |
| Apr 13, 20263:33 PM ET | International Generosity Foundation Trust | 13D | 6.70%2.73M shares | New | Feb 3, 2026 | SEC |
| Feb 11, 20256:43 PM ET | Cawood Frank Wayne | 13G/A | 8.40%3.38M shares | – | Dec 31, 2024 | SEC |
| Jan 20, 2023 | M&G Investment Management Ltd | 13G/AOld format | – | – | – | SEC |
| Oct 7, 2022 | M&G Investment Management Ltd | 13GOld format | – | New | – | SEC |
| Feb 11, 2022 | Oxford Science Enterprises plc | 13GOld format | – | New | – | SEC |
| Jan 19, 2022 | M&G Alternatives Investment Management Ltd | 13G/AOld format | – | – | – | SEC |
| Nov 5, 2021 | M&G Alternatives Investment Management Ltd | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Barinthus Biotherapeutics plc. shares.
No Form 144 notices for Barinthus Biotherapeutics plc. are on file.